Copyright © Inderes 2011 - present. All rights reserved.

Spago Nanomedical

0,22

 

SEK

 

+6,8 %

SPAGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Vær den første som følger denne virksomhed
Sammenligne
+6,8%
+12,24%
+25%
-5,98%
-24,66%
-35,67%
-95,14%
-98,36%
-98,07%

Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.

Læs mere
Markedsværdi
76,6 mio. SEK
Aktieomsætning
38,7 t SEK
Omsætning
1,2 mio.
EBIT %
-3.589,17 %
P/E
-
Udbytteafkast, %
-
Finanskalender
6.2
2025

Årsrapport '24

7.5
2025

Delårsrapport Q1'25

20.8
2025

Delårsrapport Q2'25

ViserAlle indholdstyper

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.